1. Home
  2. SFST vs MRVI Comparison

SFST vs MRVI Comparison

Compare SFST & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFST
  • MRVI
  • Stock Information
  • Founded
  • SFST 1999
  • MRVI 2014
  • Country
  • SFST United States
  • MRVI United States
  • Employees
  • SFST N/A
  • MRVI N/A
  • Industry
  • SFST Major Banks
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFST Finance
  • MRVI Health Care
  • Exchange
  • SFST Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • SFST 285.9M
  • MRVI 312.4M
  • IPO Year
  • SFST 1999
  • MRVI 2020
  • Fundamental
  • Price
  • SFST $44.64
  • MRVI $2.62
  • Analyst Decision
  • SFST Buy
  • MRVI Hold
  • Analyst Count
  • SFST 1
  • MRVI 10
  • Target Price
  • SFST $51.00
  • MRVI $6.84
  • AVG Volume (30 Days)
  • SFST 23.8K
  • MRVI 1.9M
  • Earning Date
  • SFST 07-22-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • SFST N/A
  • MRVI N/A
  • EPS Growth
  • SFST 58.49
  • MRVI N/A
  • EPS
  • SFST 2.69
  • MRVI N/A
  • Revenue
  • SFST $102,879,000.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • SFST $6.08
  • MRVI N/A
  • Revenue Next Year
  • SFST $13.23
  • MRVI $10.91
  • P/E Ratio
  • SFST $16.45
  • MRVI N/A
  • Revenue Growth
  • SFST 15.60
  • MRVI N/A
  • 52 Week Low
  • SFST $29.14
  • MRVI $1.67
  • 52 Week High
  • SFST $45.91
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • SFST 77.22
  • MRVI 56.42
  • Support Level
  • SFST $39.03
  • MRVI $2.35
  • Resistance Level
  • SFST $39.86
  • MRVI $2.93
  • Average True Range (ATR)
  • SFST 0.95
  • MRVI 0.17
  • MACD
  • SFST 0.40
  • MRVI -0.03
  • Stochastic Oscillator
  • SFST 96.71
  • MRVI 47.01

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: